Pilulka Lekarny AS (XPRA:PINK) FCF Margin % : -3.28% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Pilulka Lekarny AS FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Pilulka Lekarny AS's Free Cash Flow for the six months ended in Dec. 2023 was Kč-70 Mil. Pilulka Lekarny AS's Revenue for the six months ended in Dec. 2023 was Kč2,132 Mil. Therefore, Pilulka Lekarny AS's FCF Margin % for the quarter that ended in Dec. 2023 was -3.28%.

As of today, Pilulka Lekarny AS's current FCF Yield % is -19.13%.

The historical rank and industry rank for Pilulka Lekarny AS's FCF Margin % or its related term are showing as below:

XPRA:PINK' s FCF Margin % Range Over the Past 10 Years
Min: -4.7 Med: -2.85 Max: -1.14
Current: -3.28

During the past 6 years, the highest FCF Margin % of Pilulka Lekarny AS was -1.14%. The lowest was -4.70%. And the median was -2.85%.

XPRA:PINK's FCF Margin % is ranked worse than
62.13% of 668 companies
in the Healthcare Providers & Services industry
Industry Median: 1.36 vs XPRA:PINK: -3.28

Pilulka Lekarny AS FCF Margin % Historical Data

The historical data trend for Pilulka Lekarny AS's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pilulka Lekarny AS FCF Margin % Chart

Pilulka Lekarny AS Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-1.14

-2.41

-4.70

-3.28

Pilulka Lekarny AS Semi-Annual Data
	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
FCF Margin %	Get a 7-Day Free Trial			-	-1.14	-2.41	-4.70	-3.28

Competitive Comparison of Pilulka Lekarny AS's FCF Margin %

For the Pharmaceutical Retailers subindustry, Pilulka Lekarny AS's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pilulka Lekarny AS's FCF Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pilulka Lekarny AS's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Pilulka Lekarny AS's FCF Margin % falls into.

Pilulka Lekarny AS FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Pilulka Lekarny AS's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-69.92	/	2131.849
	=	-3.28 %

Pilulka Lekarny AS's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-69.92	/	2131.849
	=	-3.28 %

Pilulka Lekarny AS FCF Margin % Related Terms

Thank you for viewing the detailed overview of Pilulka Lekarny AS's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Pilulka Lekarny AS (XPRA:PINK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pilulka Lekarny AS (XPRA:PINK) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Drahobejlova 1073/36, Prague, CZE, 190 00

Website

https://www.pilulka.cz

Pilulka Lekarny AS operates an online pharmaceutical store by distribution of medicinal products. The store offers over-the-counter-drugs, dietary supplements, baby foods, mother care products, cosmetics, other prescription drugs, sport nutritional products, diagnostic test kits, orthopaedic supplies, first aid kits, and other related products.

Pilulka Lekarny AS (XPRA:PINK) Headlines

From GuruFocus

Top 5 4th Quarter Trades of LEE DANNER & BASS INC

By GuruFocus Research GuruFocus Editor • 02-02-2023

LEE DANNER & BASS INC Buys 3, Sells 2 in 3rd Quarter

By GuruFocus Research GuruFocus Editor • 10-31-2022